Regulus Therapeutics Inc. (RGLS)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	26.37	23.77	24.23	60.38	31.09	34.12
Short-Term Investments	60.94	-	14.93	-	-	-
Cash & Short-Term Investments	87.31	23.77	39.16	60.38	31.09	34.12
Cash Growth	183.64%	-39.31%	-35.15%	94.24%	-8.89%	144.86%
Receivables	-	-	-	-	0.5	1.14
Inventory	3.23	3.01	3.01	3.01	3.31	3.92
Prepaid Expenses	1.09	1.34	1.85	1.78	1.83	1.22
Restricted Cash	0.06	0.06	0.06	0.06	-	-
Total Current Assets	91.69	28.18	44.08	65.24	36.73	40.41
Property, Plant & Equipment	2.05	2.54	2.58	2.85	0.73	1.39
Other Intangible Assets	0.03	0.03	0.06	0.08	0.13	0.27
Other Long-Term Assets	-	-	-	0.29	0.02	0.02
Total Assets	93.76	30.75	46.72	68.45	37.6	42.08
Accounts Payable	0.79	0.2	0.18	0.29	0.54	1.32
Accrued Expenses	4.93	4.59	4.42	3.65	3.42	2.59
Current Portion of Long-Term Debt	-	1.33	4.51	-	4.65	14.63
Current Portion of Leases	0.76	0.71	0.65	0.59	0.47	0.64
Current Unearned Revenue	-	-	-	-	-	0.01
Other Current Liabilities	-	1.67	1.9	0.71	2.5	2.4
Total Current Liabilities	6.48	8.51	11.66	5.23	11.58	21.6
Long-Term Debt	-	-	-	4.67	-	-
Long-Term Leases	0.48	1.06	1.77	2.42	-	0.47
Other Long-Term Liabilities	-	-	-	1.18	-	-
Total Liabilities	6.96	9.56	13.43	13.5	11.58	22.07
Common Stock	0.07	0.02	0.02	0.02	0.07	0.02
Additional Paid-In Capital	633.39	534.38	516.46	509.79	453	431.31
Retained Earnings	-546.78	-513.21	-483.18	-454.85	-427.05	-411.32
Comprehensive Income & Other	0.12	-	-0.01	-	-	-
Total Common Equity	86.8	21.18	33.29	54.95	26.02	20.01
Shareholders' Equity	86.81	21.19	33.29	54.96	26.03	20.02
Total Liabilities & Equity	93.76	30.75	46.72	68.45	37.6	42.08
Total Debt	1.24	3.1	6.93	7.68	5.13	15.74
Net Cash (Debt)	86.07	20.67	32.23	52.7	25.96	18.38
Net Cash Growth	222.14%	-35.89%	-38.84%	103.00%	41.26%	-
Net Cash Per Share	1.91	1.09	2.11	6.15	7.42	10.65
Filing Date Shares Outstanding	65.5	65.47	16.84	14.6	7.25	2.1
Total Common Shares Outstanding	65.5	20.22	16.84	14.6	6.74	2.1
Working Capital	85.21	19.67	32.42	60.01	25.15	18.81
Book Value Per Share	1.33	1.05	1.98	3.76	3.86	9.52
Tangible Book Value	86.78	21.15	33.22	54.87	25.9	19.75
Tangible Book Value Per Share	1.32	1.05	1.97	3.76	3.84	9.39
Machinery	-	5.07	4.84	4.48	5.25	5.25
Construction In Progress	-	0.13	-	-	-	-
Leasehold Improvements	-	0.12	0.12	0.12	0.08	0.08

Source: S&P Capital IQ. Standard template. Financial Sources.